Ameritas Investment Partners, Inc. - BLACK DIAMOND THERAPEUTICS I ownership

BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 111 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Ameritas Investment Partners, Inc. ownership history of BLACK DIAMOND THERAPEUTICS I
ValueSharesWeighting
Q1 2022$4,000
-50.0%
1,5410.0%0.00%
Q4 2021$8,000
-38.5%
1,5410.0%0.00%
Q3 2021$13,000
-31.6%
1,5410.0%0.00%
-100.0%
Q2 2021$19,000
-48.6%
1,5410.0%0.00%0.0%
Q1 2021$37,000
-24.5%
1,5410.0%0.00%
-50.0%
Q4 2020$49,000
+4.3%
1,5410.0%0.00%0.0%
Q3 2020$47,000
+6.8%
1,541
+46.8%
0.00%0.0%
Q2 2020$44,000
+69.2%
1,0500.0%0.00%
+100.0%
Q1 2020$26,0001,0500.00%
Other shareholders
BLACK DIAMOND THERAPEUTICS I shareholders Q4 2020
NameSharesValueWeighting ↓
NEA Management Company, LLC 3,449,845$110,568,0002.92%
Boxer Capital, LLC 2,014,858$64,576,0002.08%
RA Capital Management 2,589,904$83,006,0001.16%
Artal Group S.A. 1,646,517$52,771,0001.13%
Burrage Capital Management LLC 34,891$1,118,0000.85%
Bellevue Group AG 1,403,000$44,967,0000.52%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 802,511$25,720,0000.51%
Ikarian Capital, LLC 293,941$9,421,0000.42%
Avoro Capital Advisors LLC 640,000$20,512,0000.35%
Logos Global Management LP 123,465$3,957,0000.34%
View complete list of BLACK DIAMOND THERAPEUTICS I shareholders